TrialKidney international2021

Subgroup analysis of the ASPirin in Reducing Events in the Elderly randomized clinical trial suggests aspirin did not improve outcomes in older adults with chronic kidney disease.

Rory Wolfe et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.